thiazolyl blue has been researched along with icariin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gu, LQ; Huang, M; Huang, SL; Huang, ZS; Li, YP; Liu, DF; Ou, TM | 1 |
Bi, L; Cao, L; Chen, J; Fan, J; Jiang, S; Jin, D; Nan, K; Pei, G; Wang, D; Wu, T | 1 |
2 other study(ies) available for thiazolyl blue and icariin
Article | Year |
---|---|
Synthesis and antimultidrug resistance evaluation of icariin and its derivatives.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavonoids; Humans; Inhibitory Concentration 50; Models, Chemical; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Time Factors | 2009 |
A combined chitosan/nano-size hydroxyapatite system for the controlled release of icariin.
Topics: Alkaline Phosphatase; Animals; Bone Marrow Cells; Chitosan; Drug Carriers; Drug Delivery Systems; Durapatite; Flavonoids; Hydrolysis; Kinetics; Mice; Mice, Inbred BALB C; Nanoparticles; Nanotechnology; Porosity; Stress, Mechanical; Stromal Cells; Technology, Pharmaceutical; Tetrazolium Salts; Thiazoles | 2012 |